Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

[1]  E. Burns,et al.  Lymphadenectomy in Gastric Carcinoma: A Prospective and Prognostic Study , 1992 .

[2]  G. Fleuren,et al.  Factors influencing noncompliance and contamination in a randomized trial of “Western” (r1) versus “Japanese” (r2) type surgery in gastric cancer , 1994, Cancer.

[3]  T. Yamaguchi,et al.  End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma. , 1997, British Journal of Cancer.

[4]  J. Siewert,et al.  Prognostic relevance of systematic lymph node dissection in gastric carcinoma , 1994, The British journal of surgery.

[5]  A. Axon,et al.  Preservation of the spleen improves survival after radical surgery for gastric cancer. , 1995, Gut.

[6]  A. Axon,et al.  Gastric cancer: a curable disease in Britain. , 1993, BMJ.

[7]  V. Schumpelick,et al.  Principles of radical surgery in gastric carcinoma. , 1989, Hepato-gastroenterology.

[8]  Tanaki Kajitani,et al.  The general rules for the gastric cancer study in surgery and pathology , 1981, The Japanese journal of surgery.

[9]  M. Mine,et al.  End results of gastrectomy for gastric cancer: effect of extensive lymph node dissection. , 1970, Surgery.

[10]  P. Fayers,et al.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial , 1996, The Lancet.

[11]  J. Hermans,et al.  Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients , 1995, The Lancet.

[12]  K. Takeda.  Cancer of the stomach in Japan from the viewpoint of pathological anatomy. , 1955, Schweizerische Zeitschrift fur Pathologie und Bakteriologie. Revue suisse de pathologie et de bacteriologie.

[13]  M. Brennan,et al.  Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. , 1991, Archives of surgery.

[14]  T. Nakajima,et al.  Surgery and adjuvant chemotherapy for gastric cancer. , 1989, Hepato-gastroenterology.